FindTrial
Sign In

Standard Hartala Bhasma in the management of Vatarakta (Gout).

"Scientific evaluation of Hartala Bhasma with special reference to vata-rakta"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/12/007620
Enrollment
30
Registered
2016-12-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patient having vatarakta(gout)symptoms.

Interventions

Intervention1: Hartala Bhasma (oral): 30 mg. B.D. with honey for 6 Week Intervention2: Hartala Bhasma: 30 mg. Hartala Bhasma (oral) B.D. Control Intervention1: no treatment: no treatment

Sponsors

jsayuveda mahavidyala
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Patient having classical symptoms of vatarakta (gout) will be selected from OPD & IPD of P.D .Patel hospital, J.S. ayurveda mahavidyalaya . • Both the sexes having age between 18 to 60. • Detail proforma will be design with the help of available literary material and administration of medicine will be carried out. This part of thesis also comprises clinical observation.

Exclusion criteria

Exclusion criteria: • Age below 18 and above 60 years. • Patient with associated disease like cancer, tuberculosis, heart disease, diabetes mellitus, hypertension, HIV & Chronic secondary infection if any. • Pregnant women • Lactating women • Patient of any other severe illness.

Design outcomes

Primary

MeasureTime frame
under observationTimepoint: under observation—

Secondary

MeasureTime frame
under observationTimepoint: -—

Countries

India

Contacts

Public ContactDr P U Vaishnav

j s ayurveda mahavidyalaya

ayurvednadiad@gmail.com9824958522

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026